Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

A Phase II Study of MLN0128 (TAK-228) in Relapsed and/or Refractory Acute Lymphoblastic Leukemia

Protocol: OSU-16281

Full Title

A Phase II Study of MLN0128 (TAK-228) in Relapsed and/or Refractory Acute Lymphoblastic Leukemia (ALL)

Leukemia Acute Lymphoblastic Leukemia